Zhejiang Hisun Pharmaceutical Co Ltd (600267)

Currency in CNY
10.31
-0.20(-1.90%)
Closed·
600267 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.3010.55
52 wk Range
8.1313.06
Key Statistics
Bid/Ask
10.32 / 10.33
Prev. Close
10.51
Open
10.54
Day's Range
10.3-10.55
52 wk Range
8.13-13.06
Volume
8.7M
Average Volume (3m)
12.91M
1-Year Change
16.4972%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600267 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.50
Downside
-27.26%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Zhejiang Hisun Pharmaceutical Co Ltd Company Profile

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is based in Taizhou, China.

Employees
7994
Market
China

Compare 600267 to Peers and Sector

Metrics to compare
600267
Peers
Sector
Relationship
P/E Ratio
21.9x22.6x−0.5x
PEG Ratio
0.01−0.290.00
Price/Book
1.4x2.8x2.6x
Price / LTM Sales
1.2x3.0x3.3x
Upside (Analyst Target)
−27.3%27.1%47.0%
Fair Value Upside
Unlock4.9%5.9%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 7.50
(-27.26% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.47%
Dividend Yield
2.04%
Industry Median 1.45%
Annualised payout
0.21
Paid unevenly
5-Years Growth
+33.24%
Growth Streak

Earnings

Latest Release
Oct 27, 2025
EPS / Forecast
0.14 / 0.12
Revenue / Forecast
2.67B / --
EPS Revisions
Last 90 days

600267 Income Statement

FAQ

What Is the Zhejiang Hisun Pharm (600267) Stock Price Today?

The Zhejiang Hisun Pharm stock price today is 10.31.

What Stock Exchange Does Zhejiang Hisun Pharm Trade On?

Zhejiang Hisun Pharm is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Zhejiang Hisun Pharm?

The stock symbol for Zhejiang Hisun Pharm is "600267."

What Is the Zhejiang Hisun Pharm Market Cap?

As of today, Zhejiang Hisun Pharm market cap is 11.99B.

What Is Zhejiang Hisun Pharm's Earnings Per Share (TTM)?

The Zhejiang Hisun Pharm EPS (TTM) is 0.47.

When Is the Next Zhejiang Hisun Pharm Earnings Date?

Zhejiang Hisun Pharm will release its next earnings report on Apr 08, 2026.

From a Technical Analysis Perspective, Is 600267 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zhejiang Hisun Pharm Stock Split?

Zhejiang Hisun Pharm has split 3 times.

How Many Employees Does Zhejiang Hisun Pharm Have?

Zhejiang Hisun Pharm has 7994 employees.

What is the current trading status of Zhejiang Hisun Pharm (600267)?

As of Feb 16, 2026, Zhejiang Hisun Pharm (600267) is trading at a price of 10.31, with a previous close of 10.51. The stock has fluctuated within a day range of 10.30 to 10.55, while its 52-week range spans from 8.13 to 13.06.

What Is Zhejiang Hisun Pharm (600267) Price Target According to Analysts?

The average 12-month price target for Zhejiang Hisun Pharm is CNY7.50, with a high estimate of CNY7.5 and a low estimate of CNY7.5. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an -27.26% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.